Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase 3 multicenter randomized double-blind trial of flurbiprofen cataplasm for knee osteoarthritis
CTR20243333Phase 3Active
- Sponsor
- Hainan Huitong Biopharmaceutical Technology
- Start
- Sep 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of flurbiprofen in knee osteoarthritis (OA), sponsored by Hainan Huitong Biopharmaceutical Technology. Started Sep 2024; status: active.
02
Drugs
flurbiprofen
03
Conditions
knee osteoarthritis (OA)
Beyond the preview
Go deeper on CTR20243333.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20243333.